DK180682A - Fremgangsmaade til fremstilling af et fibrinolytisk aktivt kar-princip og herved vundet enzymatisk produkt - Google Patents

Fremgangsmaade til fremstilling af et fibrinolytisk aktivt kar-princip og herved vundet enzymatisk produkt Download PDF

Info

Publication number
DK180682A
DK180682A DK180682A DK180682A DK180682A DK 180682 A DK180682 A DK 180682A DK 180682 A DK180682 A DK 180682A DK 180682 A DK180682 A DK 180682A DK 180682 A DK180682 A DK 180682A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
active car
active principle
fibrinolytic active
Prior art date
Application number
DK180682A
Other languages
English (en)
Inventor
G Comi
M Pandolfi
Original Assignee
Manetti & Roberts Italo Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manetti & Roberts Italo Brit filed Critical Manetti & Roberts Italo Brit
Publication of DK180682A publication Critical patent/DK180682A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK180682A 1981-04-23 1982-04-22 Fremgangsmaade til fremstilling af et fibrinolytisk aktivt kar-princip og herved vundet enzymatisk produkt DK180682A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48332/81A IT1170913B (it) 1981-04-23 1981-04-23 Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche

Publications (1)

Publication Number Publication Date
DK180682A true DK180682A (da) 1982-10-24

Family

ID=11265948

Family Applications (1)

Application Number Title Priority Date Filing Date
DK180682A DK180682A (da) 1981-04-23 1982-04-22 Fremgangsmaade til fremstilling af et fibrinolytisk aktivt kar-princip og herved vundet enzymatisk produkt

Country Status (16)

Country Link
US (2) US4471053A (da)
EP (1) EP0064036B1 (da)
JP (1) JPS57181019A (da)
AT (1) ATE15071T1 (da)
AU (1) AU548758B2 (da)
CA (1) CA1184138A (da)
DE (1) DE3265559D1 (da)
DK (1) DK180682A (da)
ES (1) ES511604A0 (da)
IE (1) IE53107B1 (da)
IL (1) IL65448A (da)
IT (1) IT1170913B (da)
NO (1) NO821287L (da)
NZ (1) NZ200254A (da)
PT (1) PT74743B (da)
ZA (1) ZA822703B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
JPS58189122A (ja) * 1982-04-30 1983-11-04 Kaken Pharmaceut Co Ltd 高脂血症予防治療剤
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5248688A (en) * 1986-09-10 1993-09-28 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
HU209955B (en) * 1987-07-01 1994-12-28 Genentech Inc Process for producing pharmaceutical compositions containing tissue- -plasminogen-activator of poor solubility for inhibiting production and regeneration of deformities
US5215908A (en) * 1989-06-13 1993-06-01 Genencor International, Inc. Process for recovery and purification of chymosin
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
MXPA00000009A (es) 1998-06-22 2005-09-08 Autologous Wound Therapy Inc Solicitud para patente de utilidad para curativo de heridas mejorado enriquecido con plaquetas.
WO2006102488A1 (en) * 2005-03-22 2006-09-28 Cascade Medical Enterprises, Llc Systems and methods of producing membranes
DE102015010436B4 (de) * 2015-08-14 2019-01-24 Airbus Defence and Space GmbH Wabenkern für dimensionsstabile Sandwichbauteile, dessen Verwendung, Sandwichplatte mit diesem Wabenkern und Verfahren zur Herstellung des Wabenkerns

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998847A (en) * 1972-10-25 1976-12-21 Schering Aktiengesellschaft 9,10-secoestrane derivatives and their production
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
US4381346A (en) * 1979-11-13 1983-04-26 Huasin Syed S Isolation of plasminogen activators useful as therapeutic and diagnostic agents
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent

Also Published As

Publication number Publication date
IL65448A0 (en) 1982-07-30
DE3265559D1 (en) 1985-09-26
ATE15071T1 (de) 1985-09-15
IE820952L (en) 1982-10-23
PT74743A (en) 1982-05-01
NZ200254A (en) 1985-07-12
NO821287L (no) 1982-10-25
JPS57181019A (en) 1982-11-08
ES8501797A1 (es) 1984-12-01
IT8148332A0 (it) 1981-04-23
ES511604A0 (es) 1984-12-01
CA1184138A (en) 1985-03-19
IT1170913B (it) 1987-06-03
EP0064036B1 (en) 1985-08-21
AU548758B2 (en) 1986-01-02
ZA822703B (en) 1983-03-30
AU8237582A (en) 1982-10-28
US4532129A (en) 1985-07-30
PT74743B (en) 1983-11-09
US4471053A (en) 1984-09-11
EP0064036A1 (en) 1982-11-03
IE53107B1 (en) 1988-06-22
IL65448A (en) 1985-07-31

Similar Documents

Publication Publication Date Title
DK180682A (da) Fremgangsmaade til fremstilling af et fibrinolytisk aktivt kar-princip og herved vundet enzymatisk produkt
DK36991A (da) Vaevsplasminoaktivator-(t-pa)-variant med zymogene eller fibrinspecifikke eller plasmakoagel-specifikke egenskaber, fremgangsmaade til fremstilling deraf, dna-sekvens, som koder for varianten, replicerbar udtrykkelsesvektor for denne og vaertsceller transformeret med vektoren
NO914217L (no) Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
FI843615A0 (fi) Nitroesterprodukt foer koronarterapi.
AU524777B2 (en) Isolation of tissue protein ppg.
ES494343A0 (es) Procedimiento de obtencion de un activador del plasminogeno
ES535409A0 (es) Procedimiento para pasterizar un plasma de radical-humano
PT85317A (fr) Procede pour l:obtention d:imunotoxines par couplage d:un anticorps avec une proteine trichosanthine ou trickokirine
ES553803A0 (es) Procedimiento para determinar un activador de plasminogeno
FI921847A0 (fi) Farmaceutisk komposition som har endoproteolytisk aktivitet, foerfarande foer endoproteolytisk behandling av (prekursor)proteiner samt foerfarande foer (mikro)bio- logisk framstaellning av proteiner.
AU570574B2 (en) Depolymerase enzymes and treatment of fireblight
ES8604990A1 (es) Procedimiento para la inactivacion de sustancias que provocan reacciones de incompatibilidad en productos sanguineos
DK325289D0 (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
EP0576038A3 (en) Method for measuring tissue plasminogen activator, antithrombin iii and soluble fibrin
ES2058931T3 (es) Un reactivo para la deteccion de actividad fibrinolitica.
ES2067221T3 (es) Activador de plasminogeno del tejido que tiene propiedades especificas para la fibrina.
EP0326013A3 (en) Novel proteins derived from human alpha2-plasmin inhibitor or proteins similar thereto
NO168352C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-allen-alfa-amino-syrer
UA15579A (uk) Раhозагоювальhий засіб
ES2066733B1 (es) Complejo consistente en un activador del plasminogeno y albumina de suero y procedimiento para prepararlo.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment